Journal Guide
Following fields are empty!
Omics
Access the Genetic Engineering & Biotechnology News (GEN)podcast interview with Eugene Kolker, PhD, Seattle Children's Hospital, Seattle Children's Research Institute, and Editor-in-Chief, OMICS and Vural Ozdemir, MD, PhD, University of Montreal here:THE EMERGING FIELD OF NUTRIGENOMICSOMICS: A Journal of Integrative Biology is the only peer-reviewed journal to span all the OMICS-es to date, including: Genomics (the quantitative study of genes, regulatory and non-coding sequences) Transcriptomics (RNA and gene expression) Proteomics (protein expression) Metabolomics (metabolites and metabolic networks)Additionally, the Journal explores advances in the era of post-genomic biology and medicine, including: Pharmacogenomics (the quantitative study of how genetics affects hosts' responses to drugs) Physiomics (physiological dynamics and functions of whole organisms)The Journal covers the integration of many areas of biology and reports on the latest omics research, developments, and discoveries such as: Physical mapping and sequencing Gene and protein expression Peptide identifications Bacterial coding capabilities Developments in plant research Spectral analysis methods.
Omni-Akuatika
Omnia. Derecho y Sociedad
Omnis Cellula
Omsk scientific bulletin. Series "Aviation-rocket and power engineering"
Omsk scientific bulletin. Series Society. History. Modernity
On the Boundary of Two Worlds: Identity, Freedom, and Moral Imagination in the Baltics
On the W@terfront
OnLine Journal of Biological Sciences
On_Culture
Onco
Onco Critical Care
OncoImmunology
© 2014 Thomson Reuters, Journal Citation Reports ® for 2014 ranks OncoImmunology 16 out of 148 in Immunology and 21 out of 211 in Oncology.
Aims & Scope: Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now create a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.
OncoImmunology will accept high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will be welcome.
MIATA Compliance
The immune monitoring community has recently established the consensus framework MIATA(“Minimal Information About T Cell Assays”) for reporting of T-cell assay results, which promote objective and thorough interpretation of data and the comparability of results. OncoImmunology supports and encourages the implementation of the MIATA guidelines .
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
OncoMagazine
OncoTargets and Therapy
OncoTargets and Therapy is an international, peer-reviewed journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. In terms of therapy, palliative care is also included as part of the overall patient care process. The journal will also focus on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.
Oncogene
Oncogene covers all aspects of the structure and function of oncogenes, especially: * Cellular oncogenes and their mechanism of activation * Structure and function of their encoded proteins * Oncogenes of the DNA and RNA tumour viruses * The molecular oncology of human tumours * Tumour suppressor genes * Growth regulatory genes * Cell cycle control * Growth factors and receptors * Apoptosis * Immortalisation and cellular senescence.
Oncogenesis
Brought to you by the editorial team of Oncogene, Oncogenesis is a peer-reviewed online journal that publishes full-length papers exploring the molecular basis of cancer and related phenomena. It seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics.
Oncohematology
Oncolog-Hematolog.ro
Oncologie
Oncologie est la revue francophone de référence pour la formation continue des oncologues.Elle apporte, dans une approche multidisciplinaire, des réponses synthétiques à des questions qui se posent dans la pratique quotidienne, à travers des dossiers thématiques réunissant les meilleurs experts et des rubriques récurrentes (DPC, Revue de presse, Psycho-Oncologie, Soins de support, Sénologie…).Oncologie fait le lien entre tous ceux qui font avancer la cancérologie : biologistes, thérapeutes, épidémiologistes, pathologistes, diagnosticiens... et ceux sur le terrain : cancérologues médicaux, radiothérapeutes, chirurgiens, spécialistes d'organe, spécialistes des soins de supports, psychologues, généralistes... Dans cette perspective, Oncologie publie, après soumission au comité de lecture, des revues générales, des articles originaux et de synthèse, des outils DPC et des recommandations et référentiels (Recommandations de Saint-Paul-de-Vence sur le cancer du sein et les soins de supp